• Log In or Create Account
  • CROI
  • Conference on Bacteriophages
  • RWHAP CLINICAL CONFERENCE
  • Podcasts
  • Slides
  • Question of the Week
  • Guidelines
  • Contact
Advanced Search
Outcomes: IAS-USA Activities from July to September 2023 - IAS-USA
  • CME Courses
    • HIV In-Person and Virtual Courses
    • Current On-Demand Courses
    • About Courses
  • CME Webinars
    • Upcoming Webinars
    • Current On-Demand Webinars
    • MATE Act CME
    • About Webinars
  • Dialogues
    • Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
    • On-Demand Dialogues
    • About Dialogues
  • Topics In Antiviral Medicine
    • Current Issues for CME
    • Previous Issues
    • TAM Policies and Practices
    • Permission Request Form
  • HIV Drug Resistance
    • HIV Drug Resistance Resources
    • HIV Drug Resistance Mutations Chart
    • Recent Webinars
    • Journal Articles
  • Fellow Resources
    • Resources for Fellows and Others New to the HIV Field
    • On-Demand Webinars for Fellows
    • IAS-USA Guidelines and Recommendations
    • On-Demand Webcasts
    • Research Collaborations
    • Additional Resources
  • About
    • Scientific Leadership Board
    • IAS-USA Leadership Award Recipients
    • Core Faculty
    • Mission
    • Staff
    • CME
    • Funding Information
    • Careers
    • Website Policies
    • Discrimination and Harassment Policy
    • Governance
    • Suggestions and Recommendations from San Francisco Locals
    • Donate
    • FAQs

Outcomes: IAS-USA Activities from July to September 2023

OUTCOMES ASSESSMENT SURVEYS

Please take a moment to complete the outcomes survey for each activity you have participated in from July to September 2023. Your feedback will help us understand how your participation in these activities may have affected your clinical practice.

WEBINARS

August 8, 2023:
Routine and Special Immunizations for People With HIV
August 22, 2023:
(Part 1 of 6) Substance Use Disorder (SUD) 101: Why Should We Care About SUD in Patients With HIV?
August 29, 2023:
Overview of Data Presented at the 2023 International AIDS Conference
September 7, 2023:
What to Do Next: Use of Resistance Testing and Managing ART Failure in People With HIV
September 19, 2023:
(Part 2 of 6) Substance Use Disorder (SUD) 101: How Should We Care For SUD in Patients With HIV?
September 26, 2023:
Doxy-PEP: Who, When, and How?

Courses and Conferences

  • HIV In-Person and Virtual Courses
    • On-Demand HIV Courses (2026)
    • On-Demand HIV Courses (2025)
    • On-Demand HIV Courses (2024)
    • On-Demand HIV Courses (2023)
    • On-Demand HIV Courses (2022)
    • On-Demand HIV Courses (2020-2021)
    • On-Demand HIV Courses (2019)
  • The 2025 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
    • Past Ryan White HIV/AIDS Program Clinical Conferences
  • Conference on Retroviruses and Opportunistic Infections (CROI)
  • About IAS–USA Courses
Outcomes: IAS-USA Activities from July to September 2023 - IAS-USA

131 Steuart St, Suite 500, San Francisco, CA 94105

Phone: (415) 544-9400 | info@iasusa.org

  • Home
  • Activities
  • Resources
  • About
  • Contact
  • Login
  • Careers
  • Donate
  • Website Policies
© 2026 International Antiviral Society–USA. All Rights Reserved.
  • CROI
  • Conference on Bacteriophages
  • RWHAP CLINICAL CONFERENCE
  • Podcasts
  • Slides
  • Question of the Week
  • Guidelines
  • Contact
  • CME Courses
    • HIV In-Person and Virtual Courses
    • Current On-Demand Courses
    • About Courses
  • CME Webinars
    • Upcoming Webinars
    • Current On-Demand Webinars
    • MATE Act CME
    • About Webinars
  • Dialogues
    • Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
    • On-Demand Dialogues
    • About Dialogues
  • Topics In Antiviral Medicine
    • Current Issues for CME
    • Previous Issues
    • TAM Policies and Practices
    • Permission Request Form
  • HIV Drug Resistance
    • HIV Drug Resistance Resources
    • HIV Drug Resistance Mutations Chart
    • Recent Webinars
    • Journal Articles
  • Fellow Resources
    • Resources for Fellows and Others New to the HIV Field
    • On-Demand Webinars for Fellows
    • IAS-USA Guidelines and Recommendations
    • On-Demand Webcasts
    • Research Collaborations
    • Additional Resources
  • About
    • Scientific Leadership Board
    • IAS-USA Leadership Award Recipients
    • Core Faculty
    • Mission
    • Staff
    • CME
    • Funding Information
    • Careers
    • Website Policies
    • Discrimination and Harassment Policy
    • Governance
    • Suggestions and Recommendations from San Francisco Locals
    • Donate
    • FAQs
Practice Question of the Week

October 26, 2026: Body Composition and Cardiovascular Risk Reduction With GLP-1 Receptor Agonists

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been shown to both decrease weight and decrease cardiovascular events in people with and without diabetes. In people without diabetes, what proportion of the cardiovascular risk reduction is attributable to changes in body composition?
View the On-Demand Course
View Archived Questions
Leave Feedback
Subscribe